Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'

Int J Antimicrob Agents. 2021 Feb;57(2):106261. doi: 10.1016/j.ijantimicag.2020.106261. Epub 2020 Dec 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Azithromycin
  • COVID-19 Drug Treatment*
  • Coronavirus Infections*
  • Humans
  • Hydroxychloroquine / therapeutic use
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Azithromycin